YOLFTbeta
Chengdu Kanghong Pharmaceuticals Group Co Ltd

Chengdu Kanghong Pharmaceuticals Group Co Ltd

002773 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

22.43CNY-0.62 (-2.69%)

Price History

Full chart

Market Stats

Previous Close23.05
Open22.82
Day Range22.39 – 22.95
52-Week Range18.62 – 36.49
Volume9.24M
Market Cap20.08B
P/E (TTM)20.19
Forward P/E0.00
EPS1.08
Dividend Yield3.21%
Beta-0.20
50-Day Avg21.03
200-Day Avg25.04

About

Chengdu Kanghong Pharmaceutical Group Co., Ltd engages in the research, development, manufacture, and sale of pharmaceuticals and medical devices in China. It develops medicines for ophthalmic, neuropsychiatric, and others. The company was founded in 1996 and is headquartered in Chengdu, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Xiao Ke
  • Employees4.47K
  • HeadquartersNo 108, Shuxi Road, Chengdu, China, 610037, China
  • Websitehttps://www.cnkh.com

Leadership

  • Mr. Xiao KeGM, President & Director · b. 1983
  • Mr. Jian Jun ZhongCFO & VP · b. 1967
  • Mr. Jin Qun YinVP & Director · b. 1972
  • Ms. Jian Rong ZhongVP & Director · b. 1957
  • Mr. Kang DengBoard Secretary & Assistant to the President · b. 1981
  • Ms. Yanhua XuVice President · b. 1973
  • Ying Mei HeChief Accounting Officer
  • Zhigang JiangSponsor Representative

Financials

Income Statement

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue638.21M796.09M1.02B1.33B1.48B1.67B2.07B2.54B2.79B2.92B3.26B3.30B3.61B3.39B3.96B4.45B4.59B
Growth (%)-+24.74%+27.69%+30.97%+10.91%+13.40%+23.88%+22.45%+9.70%+4.70%+11.65%+1.17%+9.40%-6.00%+16.77%+12.51%+2.98%
Cost of Revenue67.40M84.02M114.95M156.98M171.31M193.67M225.50M243.62M270.11M231.44M264.52M330.22M355.66M391.66M438.84M469.43M465.41M
Gross Profit570.81M712.07M901.58M1.17B1.31B1.48B1.85B2.30B2.52B2.69B2.99B2.97B3.25B3.00B3.52B3.98B4.12B
Gross Margin89.44%89.45%88.69%88.21%88.40%88.43%89.13%90.41%90.31%92.07%91.88%89.98%90.14%88.44%88.91%89.46%89.85%
Operating Expense466.82M588.31M723.27M918.31M952.44M1.15B1.41B1.75B1.73B1.89B2.17B3.48B2.89B1.98B2.26B2.60B2.82B
Operating Income103.99M123.76M178.32M256.09M352.87M329.56M437.82M551.23M787.53M796.20M820.75M-512.29M355.18M1.02B1.26B1.38B1.30B
Operating Margin16.29%15.55%17.54%19.24%23.90%19.68%21.11%21.70%28.26%27.29%25.20%-15.55%9.85%29.96%31.87%31.02%28.26%
EBITDA131.02M168.20M236.30M307.56M355.61M376.92M475.72M580.53M747.87M722.24M783.73M-529.02M554.33M1.02B1.32B1.46B1.53B
EBITDA Margin20.53%21.13%23.25%23.10%24.08%22.51%22.93%22.86%26.84%24.76%24.06%-16.05%15.38%30.11%33.40%32.82%33.45%
Net Income82.45M108.51M165.03M202.75M315.71M273.48M393.81M496.75M644.20M694.94M718.19M-269.85M421.08M896.67M1.04B1.19B1.16B
Net Income Margin12.92%13.63%16.23%15.23%21.38%16.33%18.98%19.56%23.12%23.82%22.05%-8.19%11.68%26.46%26.40%26.75%25.36%
R&D--67.54M47.02M59.57M75.50M99.39M122.23M191.93M230.37M286.94M1.68B1.01B374.00M421.68M593.96M533.09M
R&D as % of Total Revenue--6.64%3.53%4.03%4.51%4.79%4.81%6.89%7.90%8.81%50.86%27.97%11.04%10.66%13.34%11.63%
Interest Expense-1.56M2.71M3.95M2.00M612.00K431.95K0407.19K763.71K572.80K1.14M915.19K229.44K150.78K566.02K-
Interest Expense % of Total Revenue-0.20%0.27%0.30%0.14%0.04%0.02%0.00%0.01%0.03%0.02%0.03%0.03%0.01%0.00%0.01%-

Balance Sheet

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets823.48M991.06M1.30B1.48B1.69B1.94B2.90B3.76B4.59B5.19B5.83B7.00B6.96B7.72B8.53B9.34B9.92B
Total Liabilities283.73M366.21M359.58M375.39M305.69M329.11M376.19M853.27M1.04B1.11B1.21B1.25B851.08M813.85M717.76M695.07M645.22M
Total Equity539.75M616.88M925.77M1.09B1.37B1.59B2.50B2.90B3.54B4.08B4.62B5.76B6.09B6.90B7.80B8.65B9.30B
Cash186.22M204.94M340.24M483.87M746.09M945.58M1.69B2.39B3.10B2.49B2.28B3.33B2.94B3.59B4.70B5.69B6.44B
Total Debt-60.00M57.00M42.00M5.00M5.00M-191.14M395.77M342.23M277.65M1.06M4.43M3.27M1.48M3.47M-
Net Debt-186.22M-144.94M-283.24M-441.87M-741.09M-940.58M-1.69B-2.39B-2.71B-2.15B-2.01B-3.33B-2.93B-3.58B-4.70B-5.69B-

Cash Flow

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow108.42M136.79M168.86M281.84M333.31M291.38M481.97M846.35M766.86M350.88M812.15M273.32M494.11M925.15M1.22B1.41B1.50B
Investing Cash Flow-170.17M-164.41M-148.51M-82.79M3.25M-34.42M-261.77M-250.16M75.82M-755.64M-793.95M-583.96M-803.14M-215.55M6.62M-112.06M-
Financing Cash Flow-36.03M46.34M114.96M-55.42M-73.58M-57.40M520.89M97.95M-122.56M-205.33M-230.25M1.36B-78.84M-73.85M-130.50M-344.14M-
Capital Expenditure158.27M131.76M157.25M129.51M77.16M90.27M115.83M170.23M312.88M458.45M962.88M617.07M569.42M355.21M138.87M159.39M262.48M
Free Cash Flow-49.84M5.03M11.60M152.33M256.16M201.11M366.14M676.12M453.98M-107.57M-150.73M-343.75M-75.30M569.95M1.08B1.25B1.24B
Dividends Paid16.03M24.97M140.79M39.65M37.37M54.31M60.13M89.12M100.76M188.55M188.14M244.58M91.95M91.95M137.92M349.40M552.67M
FCF to OCF-45.97%3.68%6.87%54.05%76.85%69.02%75.97%79.89%59.20%-30.66%-18.56%-125.77%-15.24%61.61%88.60%88.71%82.54%
Dividend Paid to FCF-32.16%496.15%1213.30%26.03%14.59%27.00%16.42%13.18%22.19%-175.29%-124.82%-71.15%-122.10%16.13%12.78%27.90%44.53%

Earnings

Report DateOct 27, 2015Feb 22, 2016Apr 25, 2016Aug 22, 2016Oct 25, 2016Feb 28, 2017Apr 24, 2017Aug 23, 2017Oct 22, 2017Feb 27, 2018Apr 26, 2018Aug 28, 2018Oct 22, 2018Feb 27, 2019Apr 29, 2019Aug 25, 2019Oct 30, 2019Feb 27, 2020Apr 29, 2020Aug 25, 2020Oct 26, 2020Apr 28, 2021Aug 29, 2021Oct 27, 2021Apr 29, 2022Aug 22, 2022Oct 27, 2022Apr 27, 2023Aug 27, 2023Oct 26, 2023Apr 24, 2024Aug 22, 2024Oct 25, 2024Apr 25, 2025Aug 28, 2025Oct 29, 2025Apr 24, 2026Aug 26, 2026
EPS Estimate---------0.270.220.120.27--0.120.270.270.270.180.27---0.27-------------
EPS Actual0.140.170.120.090.150.210.170.090.210.260.230.120.220.220.240.160.240.190.200.180.280.250.200.25-0.250.260.240.150.270.330.240.350.310.240.360.330.330.28
Surprise----------3.70%4.55%0.00%-18.52%--33.33%-11.11%-29.63%-25.93%0.00%3.70%----192.59%-------------
TimingPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market-After-hours----

Key Statistics & Ratios

Market Cap20.08B
Enterprise Value12.24B
Trailing P/E20.19
Forward P/E0.00
Price / Sales4.66
Price / Book2.02
EPS1.08
Book Value10.00
Revenue (TTM)4.31B
Gross Profit (TTM)3.84B
EBITDA1.30B
Profit Margin23.15%
Operating Margin24.97%
Return on Equity10.86%
Return on Assets6.79%
Shares Outstanding921.33M
Shares Float280.26M
Beta-0.20
Dividend Yield3.21%
Dividend Rate0.70
Payout Ratio74.31%

Dividends

20261×
0.70Jun 9, 2026
20251×
0.60Jun 6, 2025
20241×
0.38May 28, 2024
20231×
0.15Jun 6, 2023
20221×
0.10Jun 8, 2022
20211×
0.10Jun 11, 2021
20201×
0.28Jun 12, 2020
20191×
0.22Jun 6, 2019
20181×
0.22Jun 11, 2018
20171×
0.12Jun 1, 2017
20161×
0.10Jun 8, 2016

Stock Splits

  • Jun 6, 20191.3:1
  • Jun 8, 201615:10